Background: Differentiated thyroid cancer (DTC) has a good prognosis but a remaining risk
of recurrence and need for lifelong follow-up. The aim was to study changes in health …

Background: Although differentiated thyroid cancer (DTC) has an excellent prognosis and a
low incidence of recurrence, lifelong follow-up and medication might be needed. The aim of …

Background: Differentiated thyroid cancer (DTC) has a good prognosis but a remaining risk
of recurrence, and life-long follow-up as well as medication with levothyroxine may be …

Background Differentiated thyroid cancer (DTC) reports a poorer health‐related quality of life
(HRQoL) than a norm population. Patients' illness perceptions are modifiable and known …

Background: Despite a good prognosis, survivors of differentiated thyroid cancer (DTC) may
have reduced health-related quality of life (HRQOL) many years after treatment, and it is …

Differentiated thyroid carcinoma (DTC) generally has a favorable outcome. Thyroid disease,
treatments, stress, and comorbidity can compromise health-related quality of life (QoL) and …

Diagnosis of differentiated thyroid carcinoma (papillary or follicular) and its treatment may be
associated with a poor health-related quality of life (HRQoL), and with fear of recurrence …

Background. Given the longevity of thyroid cancer patients, any impairment in health-related
quality of life (HRQoL) during the follow-up period is of considerable concern. Therefore, the …

Objective Earlier cross-sectional studies showed that patients with differentiated thyroid
cancer (DTC) have a significant reduction of quality of life (QoL) compared to controls …

Background: Patients with malignancy suffer impairment of their quality of life (QoL). QoL
has been evaluated in thyroid cancer patients. Since 2010, a new inventory, the thyroid …